Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (241-250 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|March 15, 1997
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy TrialG N Levine, A K Jacobs, G P Keeler, et al.
Journal of the American College of Cardiology|August 1, 1996
Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experienceE J Lesnefsky, C F Lundergan, J M Hodgson, et al.
Clinical Nursing Research|May 1, 1996
Participation of nurses in decision making for seriously ill adultsM J Kennard, T Speroff, A L Puopolo, et al.
Journal of the American College of Cardiology|September 1, 1996
Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy TrialD R Holmes, K N Garratt, J M Isner, et al.
The American Journal of Cardiology|May 1, 1995
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study GroupA M Lincoff, E J Topol, R M Califf, et al.
American Heart Journal|November 13, 1998
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesK M Zabel, C B Granger, R C Becker, et al.
Circulation|August 1, 1990
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trialD O Williams, E J Topol, R M Califf, et al.
European Heart Journal|May 23, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
Circulation|July 7, 1999
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trialP B Berger, S G Ellis, D R Holmes, et al.
American Heart Journal|May 29, 2000
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapyM Cohen, S S Stinnett, B D Weatherley, et al.
Pageof 57

Showing results (241-250 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|March 15, 1997
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy TrialG N Levine, A K Jacobs, G P Keeler, et al.
Journal of the American College of Cardiology|August 1, 1996
Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experienceE J Lesnefsky, C F Lundergan, J M Hodgson, et al.
Clinical Nursing Research|May 1, 1996
Participation of nurses in decision making for seriously ill adultsM J Kennard, T Speroff, A L Puopolo, et al.
Journal of the American College of Cardiology|September 1, 1996
Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy TrialD R Holmes, K N Garratt, J M Isner, et al.
The American Journal of Cardiology|May 1, 1995
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study GroupA M Lincoff, E J Topol, R M Califf, et al.
American Heart Journal|November 13, 1998
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesK M Zabel, C B Granger, R C Becker, et al.
Circulation|August 1, 1990
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trialD O Williams, E J Topol, R M Califf, et al.
European Heart Journal|May 23, 1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromesE Braunwald, A Maseri, P W Armstrong, et al.
Circulation|July 7, 1999
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trialP B Berger, S G Ellis, D R Holmes, et al.
American Heart Journal|May 29, 2000
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapyM Cohen, S S Stinnett, B D Weatherley, et al.
Pageof 57